- 20 years at Novo Nordisk as CFO and EVP (1999 to 2019).
- Present Chairman of the Board of LEO Pharma + Vice Chairman at William Demant Foundation & Novonesis.
- Education: Copenhagen Business School; MBA 1995 + Master of Science, Economics&Auditing 1990.
Jesper Brandgaard


Awards won
Best IR by a CFO (large cap)
2011
Europe
Explore

Articles
Stay informed on critical issues affecting IR teams, gain expert analysis of market trends, buy-side insights, career advice, and more.

Peer comparison
Our new tool lets you benchmark your IR program against peers in your region and sector, uncover strengths, and identify areas for growth.

Playbooks
Packed with industry trends and insights that define best-in-class practices across key, practical, and timely aspects of an IRO’s role.

Research reports
Powered by the world’s largest survey of the buy side, sell side, and IR professionals, discover data-driven insights on running a successful IR program.